Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome

Iuorno, Maria J., Jakubowicz, Daniela J., Baillargeon, Jean-Patrice, Dillon, Pamela, Gunn, Ronald D., Allan, Geoffrey, Nestler, John E.·2002·Endocrine Practice
DOI 10.4158/ep.8.6.417

Cited by (187)

Items 101–187 of 187

  1. What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment
    Daniela Romualdi, Valeria Versace, Antonio Lanzone · 2020 · Therapeutic Advances in Reproductive Health
  2. Effects of antioxidant intervention in patients with polycystic ovarian syndrome: A systematic review and meta-analysis
    Junde Zhao, Xiaohui Sui, Qingyu Shi, Dan Su, Zhiheng Lin · 2022 · Medicine
  3. Nonpharmacologic Management of Symptoms in Females With Polycystic Ovary Syndrome: A Narrative Review
    Diana L. Speelman · 2019 · Journal of Osteopathic Medicine
  4. A systematic approach to the amplified expression, functional characterization and purification of inositol transporters from Bacillus subtilis
    Kim E. Bettaney, Preethi Sukumar, Rohanah Hussain, Giuliano Siligardi, Peter J. F. Henderson, Simon G. Patching · 2012 · Molecular Membrane Biology
  5. Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus
    Faryal Tahir, Zainab Majid · 2019 · Cureus
  6. Pioglitazone Therapy Increases Insulin-Stimulated Release of d - Chiro -Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome
    Anshu Gupta, Daniela J. Jakubowicz, John E. Nestler · 2016 · Metabolic Syndrome and Related Disorders
  7. Pharmacologic Treatment of Polycystic Ovary Syndrome: Alternate and Future Paths
    Richard S. Legro, Luciana Martel‐Duguech · 2017 · Seminars in Reproductive Medicine
  8. PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review
    G. Lentini, Alessandro Querqui, N. Monti, M. Bizzarri · 2025 · Drug Design, Development and Therapy
  9. Myo-inositol improves developmental competence and reduces oxidative stress in porcine parthenogenetic embryos
    Ali Jawad, Dongjin Oh, Hyerin Choi, Mirae Kim, Jaehyung Ham, Byoung Chol Oh, Joohyeong Lee, Sang‐Hwan Hyun · 2024 · Frontiers in Veterinary Science
  10. Experimental and in silico characterization of a biologically active inosose
    Venerando Pistarà, Giuseppe M. Lombardo, Antonio Rescifina, Alessia Bacchi, Felicia D’Andrea, Francesco Punzo · 2013 · Structural Chemistry
  11. The Effect of Preincubation Time and Myo-inositol Supplementation on the Quality of Mouse MII Oocytes
    Fatemeh Mohammadi, Mahnaz Ashrafi, Zahra Zandieh, Mohammad Najafi, Behrooz Niknafs, Fatemehsadat Amjadi, Maryam Haghighi · 2020 · Journal of Reproduction & Infertility
  12. The Effect of Prebiotics, Alone or as Part of Synbiotics, on Cardiometabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Elham Razmpoosh, Mala S. Sivanandy, Alan M. Ehrlich · 2025 · Biomedicines
  13. Potential role of d -chiro-inositol in reducing oxidative stress in the blood of nonobese women with polycystic ovary syndrome
    Dusan Simic, Tamara Nikolić Turnić, Aleksandra Dimitrijević, Aleksandar Živadinović, Jelena Milošević, Dus̆an Djurić, Vladimir I. Zivkovic, Vladimir Lj. Jakovljevic · 2022 · Canadian Journal of Physiology and Pharmacology
  14. Inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: now and the future
    Antonio Simone Laganà, Samuel Harry Myers, Gianpiero Forte, Antoine Naem, Harald Krentel, Leila Allahqoli, İbrahim Alkatout, Vittorio Unfer · 2024 · Expert Opinion on Drug Metabolism & Toxicology
  15. d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI)
    Simona Dinicola, Vittorio Unfer, Christophe Olivier Soulage, Maria Isidora Margarita Yap‐Garcia, Arturo Bevilacqua, Salvatore Benvenga, Daniele Barbaro, Artur Wdowiak, Maurizio Nordio, Didier Dewailly et al. · 2024 · Gynecologic and Obstetric Investigation
  16. Women’s Health
    Melinda R. Ring · 2017 · Primary Care Clinics in Office Practice
  17. Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials
    Jyotsna Pundir · 2017
  18. Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial
    Meena Gul, Hina Khan, Bushra Rauf, Syed Murtaza Shah Bukhari, Ehtesham Ehtesham, Muhammad Omar Malik, Fawad Ali Shah, Fawaz E. Alanazi, Mohsin Shah · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  19. Mechanisms of Insulin Resistance Formation in Polycystic Ovarian Disease and Therapeutic Effects from Myo Inositol
    Чернуха Галина Евгеньевна, M.A. Udovichenko, A.A. Naydukova · 2019 · Doctor Ru
  20. Dietary Approaches and Alternative Therapies for Polycystic Ovary Syndrome
    Michael L. Lydic, Vijaya Juturu · 2008 · Current Nutrition & Food Science
  21. Bacillus subtilis IolQ (DegA) is a transcriptional repressor of iolX encoding NAD+-dependent scyllo-inositol dehydrogenase
    Dong‐Min Kang, Christophe Michon, Tetsuro Morinaga, Kosei Tanaka, Shinji Takenaka, Shu Ishikawa, Ken‐ichi Yoshida · 2017 · BMC Microbiology
  22. A 500-year-old medicine container discovered near Misgund, Eastern Cape, South Africa: Residue characterisation by GC-MS
    Justin Bradfield, Stephan M Woodborne, Jeremy C. Hollmann, Ian A. Dubery · 2023 · South African Journal of Science
  23. Systematic analysis of the biological roles and pharmacological properties of D-chiro-inositol
    Ольга Алексеевна Громова, Ivan Yu. Torshin, Elena Vital'evna Uvarova, Natalya Igorevna Tapilskaya, Калачева Алла Геннадьевна · 2020 · GYNECOLOGY
  24. An innovative approach to polycystic ovary syndrome
    Mariano Bizzarri, Patrizia Logoteta, Giovanni Monastra, Antonio Simone Laganà · 2021 · Journal of Obstetrics and Gynaecology
  25. Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)—Women’s Endocrinology
    Costanzo Moretti, Marco Bonomi, Paola Dionese, Silvia Federici, Anna Maria Fulghesu, Jacopo Giannelli, Roberta Giordano, Laura Guccione, Elisa Maseroli, Paolo Moghetti et al. · 2024 · Journal of Endocrinological Investigation
  26. Synthesis and biological activities of d - chiro -inositol analogues with insulin-like actions
    Phillip M. Rendle, F. Kassibawi, K.A. Johnston, J.B. Hart, Scott A. Cameron, Andrew Falshaw, Gavin F. Painter, Kerry Martin Loomes · 2016 · European Journal of Medicinal Chemistry
  27. Fagopyritols: occurrence, biosynthesis, analyses and possible role
    Ralph L. Obendorf, Marcin Horbowicz, Takashi Ueda, Kathryn J. Steadman · 2012
  28. PCOS from Lifestyle to the Use of Inositol and Insulin Sensitizers
    Alessandro David Genazzani, Alessia Prati, Giulia Despini, Giulia Maria Francesca Marini, Federica Ricchieri · 2014 · ISGE series
  29. Know your Enemy: The Rationale of Using Inositol in the Treatment of Polycystic Ovary Syndrome
    Antonio Simone Laganà · 2013 · Endocrinology & Metabolic Syndrome
  30. Inositol in women suffering from acne and PCOS: a randomized study
    Michele Pezza, Valentina Carlomagno · 2017 · Global Dermatology
  31. Inositol for subfertile women with polycystic ovary syndrome
    Marian G. Showell, Rebecca Mackenzie-Proctor, Vanessa Jordan, Ruth Hodgson, Julie Brown, Cindy M. Farquhar · 2016 · Cochrane Database of Systematic Reviews
  32. Genetic Variability Analysis in Germplasm Collections of Buckwheat
    Guruprasad Hiremath, Srinivas A. Desai, V Lavanya, N. Bhumika Patel, T.N. Satisha, Suma S. Biradar, V. Rudra Naik · 2017 · International Journal of Current Microbiology and Applied Sciences
  33. CONTROVERSIES IN ENDOCRINOLOGY : A MODERN MEDICAL QUANDARY: POLYCYSTIC OVARY SYNDROME, INSULIN RESISTANCE AND ORAL CONTRACEPTIVE PILLS
    Evanthia Diamanti‐Kandarakis, Jean‐Patrice Baillargeon, M J Jurno · 2003
  34. Die “anderen” Inositole und ihre Phosphate: Synthese, Biologie und Medizin (sowie jüngste Fortschritte in dermyo‐Inositolchemie)
    MARK P. THOMAS, Stephen J Mills, Barry V. L. Potter · 2015 · Angewandte Chemie
  35. The effects of combined therapy of myo-inositol and D-chiro inositol in reduction of the individual components of metabolic syndrome in overweight PCOS patients compared to myo-inositol supplementation alone: a prospective randomised controlled trial
    Manideepa Pande, Ashish Seal, Sukanta Mishra, Arup Dasgupta, Mousumi Sengupta, Rinini Dastider · 2017 · International Journal of Reproduction Contraception Obstetrics and Gynecology
  36. Differential Gene Expression and Biological Analyses of Primary Hepatocytes Following D-Chiro-Inositol Supplement
    Feier Cheng, Shaojun Yun, Jinling Cao, Mingchang Chang, Junlong Meng, Jingyu Liu, Yanfen Cheng, Cuiping Feng · 2021 · Frontiers in Endocrinology
  37. A Paradox: The Roles of Inositolphosphoglycans in mediating insulin sensitivity and Hyperandrogenism in the Polycystic Ovary Syndrome
    Kai I. Cheang, Paulina A. Essah, John E. Nestler · 2004 · HORMONES
  38. Use of Inositols in Polycystic Ovary Syndrome
    Olga A. Pustotina · 2020 · Effective Pharmacotherapy
  39. Diet and exercise in the management of PCOS: Starting from the basics
    Georgios Κ. Markantes, Gina Tsichlia, Neoklis A. Georgopoulos · 2021 · Elsevier eBooks
  40. Insulin-sensitizing effect and antioxidant action of alpha lipoic acid in oligomenorrheic women with polycystic ovary syndrome
    Elisa SCARINCI, Giovanna NOTARISTEFANO, Anna TROPEA, Simone M. FABOZZI, Ornella ALESIANI, Elisabetta MEUCCI, Andrea SILVESTRINI, Marco Cintoni, Alice Diterlizzi, Antonio LANZONE et al. · 2021 · Minerva Obstetrics and Gynecology
  41. Natural Approaches for Treating Polycystic Ovary Syndrome
    Chris D. Meletis, Nieske Zabriskie · 2006 · Alternative and Complementary Therapies
  42. Management of Polycystic Ovary Syndrome
    Ephia Yasmin, Adam H. Balen · 2007 · Women s Health
  43. Biosynthesis and production of quercitols and their application in the production of pharmaceuticals: current status and prospects
    Nobuya Itoh · 2018 · Applied Microbiology and Biotechnology
  44. Glucose Transporter 4 and Peroxisome Proliferator-Activated Receptor-Alpha Overexpression Association With Cardioprotective Effects of Myoinositol and Metformin Combination in Type 2 Diabetic Rat Model
    Dalia Abdel-Wahab Mohamed, Wael M. Elayat, Asmaa A Abo Zeid, Mohamed F. Abdel-Salam, Nahla Mohamed Teama, Dina Sayed Abdelrahim, Yomna M. Tamim · 2021 · Journal of Endocrinology and Metabolism
  45. Treatment Options for Managing Anovulation in Women with PCOS: An Extensive Literature Review of Evidence-Based Recommendations for Future Directions
    Alessia Mahoney, Arianna D’Angelo · 2025 · Life
  46. Inositol Derivatives Stimulate Glucose Transport in Muscle Cells
    Angeline Yap, Shin Nishiumi, Ken‐ichi Yoshida, Hitoshi Ashida · 2008 · Springer eBooks
  47. PCOS Therapy
    Mariagrazia Stracquadanio, Lilliana Ciotta · 2015 · Springer eBooks
  48. Effect on insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator during weight loss in obese women with and without polycystic ovary syndrome
    Cheang, Kai I., Sistrun, Sakita N., Morel, Kelley S., Nestler, John E. · 2016 · International Journal of Endocrinology
  49. Systematic analysis of the pharmacology of myoinositol and D-chiroinositola
    Tatiana E. Bogacheva, Ольга Алексеевна Громова, Ivan Yu. Torshin · 2024 · Pharmacokinetics and Pharmacodynamics
  50. A prospective randomised controlled study on the effects of myoinositol on ovarian functions and metabolic factors in women with polycystic ovarian syndrome
    Pooja Singh, Suchismita Biswal, Santosh Kumar Verma · 2020 · International Journal of Reproduction Contraception Obstetrics and Gynecology
  51. An Overview of Sports Supplements
    Chris Lockwood · 2009 · Humana Press eBooks
  52. Pretreatment with myo-inositol in patients undergoing gonadotropins multiple follicular stimulation for IVF
    Franco Lisi · 2016 · Acta Medica International
  53. Pathogenesis of PCOS: From Metabolic and Neuroendocrine Implications to the Choice of the Therapeutic Strategy
    Alessia Prati, Andrea R. Genazzani, Alessandro David Genazzani · 2021 · ISGE series
  54. Advisory Board Italiano sulla sindrome dell'ovaio policistico (PCOS): dalle osservazioni all'esperienze cliniche sull'uso del mioinositolo (MYO) e dell'acido alfa-lipoico (ALA) per migliorare i quadri della sindrome
    Enrico Maria Ferrazzi, Paolo Moghetti, Franca Fruzzetti, Alessandra Gambineri, Anna Maria Fulghesu, Maria Elisabeth Street, Rocco Rago, Irene Cetin, Chiara Mandò, Nicoletta Di Simone et al. · 2020 · Minerva Obstetrics and Gynecology
  55. Fagopyrum esculentum
    T. K. Lim · 2012 · Springer eBooks
  56. Effects of Inositol in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Kohsuke Hayamizu, Yui Kuramochi, Akihide Sumino, Nobuo Izumo, Megumi Furukawa, Makoto Nakano · 2022 · Journal of Nutritional Health & Food Science
  57. Inositol supplementation efficacy in improving key cardiometabolic and anthropometric indices: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
    Mouloud Agajani Delavar, Parvaneh Mirabi, Sara K. Rosenkranz, Fatemeh Alibabaei-Omran, Niloufar Ahmadi, Zeinab Ghorbani · 2025 · Diabetology & Metabolic Syndrome
  58. Metformin, myo-inositol and D-chiro-inositol use and ART outcomes in women with PCOS: current results and future perspectives
    Cemil Kaya · 2026 · Journal of Health Sciences and Medicine
  59. Evidence-based pharmacology of myoinositol
    Tatiana E. Bogacheva, Ольга Алексеевна Громова, I. Yu. Torshin, Калачева Алла Геннадьевна, Т. Р. Гришина · 2026 · Pharmacoinformatics and pharmaconutritiology Current trends in data analysis
  60. Medical Management of Polycystic Ovary Syndrome
    Nadia Kabli, Togas Tulandi · 2008 · Cambridge University Press eBooks
  61. Does the combination of myo-inositol improve pregnancy outcomes in obese polycystic ovary syndrome women undergoing ovarian stimulation with clomiphene citrate?
    Mustafa Taş, Bülent Özçelik · 2019 · Journal of Surgery and Medicine
  62. Polycystic Ovary Syndrome: Pathophysiology, Presentation and Treatment a Mini-Review Article
    Dusan Simic, Katarina Stefanovic, Dus̆an Djurić, Tamara Nikolić Turnić · 2021 · Serbian Journal of Experimental and Clinical Research
  63. Abnormal blood pressure and hyperandrogenemia in first degree relatives of women with polycystic ovarian syndrome referring to gynecology clinics of Shiraz Medical University.
    Marzieh Akbarzadeh, Fatah Moradi, Dabbaghmanesh MH, Najaf Zare, Parsanezhed Me · 2014
  64. Polycystic Ovarian Syndrome
    Melinda R. Ring · 2012 · Elsevier eBooks
  65. Use of myo-inositol in the treatment of PCOS symptoms in adolescents
    Lali Pkhaladze, Vittorio Unfer, Didier Dewailly · 2023 · Elsevier eBooks
  66. Supplementation with d-chiro-inositol in women
    Antonio Simone Laganà, Cesare Aragona, Nikos Prapas · 2023 · Elsevier eBooks
  67. Role of inositol and its isomers in glucose metabolism
    О. А. Ночвіна, Elina Slyvka · 2021 · Reproductive Endocrinology
  68. Inositols and other supplements in the management of PCOS
    Vittorio Unfer, Giovanni Monastra, Marco Tilotta, Gianpiero Forte, Simona Dinicola · 2021 · Elsevier eBooks
  69. Use of Diet and Myoinositol in Postmenopausal Women: A New Approach to the Metabolic Syndrome
    Rosario D’Anna, Maria Lieta Interdonato · 2013 · Humana Press eBooks
  70. Inositolo e sindrome dell'ovaio micropolicistico
    Enrico Papaleo, M Molgora, Elena Marsiglio, Francesco Fusi, Claudio Brigante, Lavinia Quaranta, Augusto G. Ferrari · 2009 · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche)
  71. QUALITÀ OVOCITARIA IN DONNE CON PCOS TRATTATE MEDIANTE INOSITOLO
    Maria Renata Raniolo · 2012
  72. Pinitol and D-chiro-Inositol
    Kohji Yamaki · 2013 · NIPPON SHOKUHIN KOGYO GAKKAISHI
  73. Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with
    Antonio De Simone, Lagana, Luisa Barbaro, Alfonsa Pizzo · 2015
  74. Polycystic Ovarian Syndrome
    Melinda R. Ring · 2017 · Elsevier eBooks
  75. REPRODUCTIVE HEALTH AND CARDIOMETABOLIC RISK
    В. С. Чулков, Гаврилова Елена Сергеевна, Чулков Владислав Сергеевич, Elena E. Minina · 2018 · Siberian medical review
  76. Polycystic ovary syndrome: a vitamin deficiency? Floating a new pathogenesis hypothesis.
    Vittorio Unfer · 2010 · PubMed
  77. 日本文化と日本人--地域性,県民性と変化の問題
    孝男 祖父江 · 1994 · 学術月報
  78. PCOS and Assisted Reproduction Technique: Role and Relevance of Inositols
    Paolo Giovanni Artini, Elisa Malacarne, Vito Cela · 2021 · Endocrines
  79. Inositols
    John E. Nestler, Antonio Simone Laganà · 2018 · Springer eBooks
  80. Introduction to the history of inositols: A tale of scientists
    Vittorio Unfer, John E. Nestler · 2023 · Elsevier eBooks
  81. Overcoming inositol resistance
    Zdravko Asenov Kamenov, Mario Montanino Oliva · 2023 · Elsevier eBooks
  82. Nutritional support of oocyteogenesis, ovulatory menstrual cycles with folate cycle vitamins (vitamins B1, B6, B12, active form B9) and vitamin B8 vitamers (Myo- and D-chiroinositol in a ratio of 40:1) during pre-conception preparation
    О. А. Громова, Ivan Yu. Torshin, Тетруашвили Нана Картлосовна · 2025 · Medical alphabet
  83. Efficacy of pretreatment D-chiro-inositol and cyproterone acetate-ethinyl estradiol combination therapy compared to cyproterone acetate-ethinyl estradiol alone for ovarian response in polycystic ovary syndrome with high AMH
    Abanti Ghosh, Lipi Rany Saha, Fawzia Hossain, Humaira Alam, Mostafa M. Al Tarique, Rebeka Sultana, Arati K. Sharma, Jesmine Banu · 2025 · International Journal of Reproduction Contraception Obstetrics and Gynecology
  84. Additional file 1 of Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
    Dorina Greff, Anna Evelin Juhász, Váncsa, Szilárd, Alex Váradi, Sipos, Zoltán, Szinte, Julia, Sunjune Park, Hegyi, Péter, Péter Nyírády, Ács, Nándor et al. · 2023 · Figshare
  85. Study of the insulin-sensitizing effect of myo-inositol in mouse : Evaluation of the nutritional interest of a myo-inositol supplementation
    Marine L. Croze · 2013
  86. Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis
    Daniele Tienforti, Gennaro Puocci, Claudia Venditti, Valentina Gizzi, Carlo Pisano, Elisa Cocci, Elisabetta Perfetto, Francesco D'Alessandro, Luca Spagnolo, Marco Giorgio Baroni et al. · 2026 · Clinical Endocrinology
  87. D-ХИРО-ИНОЗИТОЛ: ОБЗОР КЛИНИЧЕСКИХ ПРЕИМУЩЕСТВ ПРИ ЭСТРОГЕНЗАВИСИМЫХ НАРУШЕНИЯХ У МУЖЧИН
    О.А. Громова, И.Ю. Торшин · 2026 · Фармакология & Фармакотерапия